To elucidate the role of human DMP1 (hDMP1) in breast cancer, we recently analyzed 110 tumor and normal pairs of human breast cancer samples for the alterations (gene loss or amplification) of the hDMP1-ARF-Hdm2-p53 pathway with follow up of clinical outcomes. This evidence concerns the gene CDKN2A and breast cancer.